Imagen de perfil
You should take a close look at healthcare companies. What do you expect from Pfizer?
1
Imagen de perfil
@MrMister Dividends 😂 and a small share price update
Pfizer is my 2024 turnaround candidate for me
3
Imagen de perfil
@Growthvestor The challenge that Pfizer has compared to other pharmaceuticals is its high level of debt and the fact that it has no patents of its own for its products and lives exclusively from the purchase of certificates/sales rights and collaborations. I find other pharmaceuticals more exciting. But maybe there will be a turnaround, who knows.
1